ArticleACS omega2026
Mechanistic Insights into Lysine Cyclodeaminase Catalysis.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lysine cyclodeaminase (LCD) catalyzes the conversion of l-lysine into l-pipecolic acid, a key building block for food additives and pharmaceutical intermediates. Despite its industrial relevance, LCD displays a narrow substrate scope, efficiently converting l-lysine, while bulkier derivatives such as l-lysine ethyl ester fail to undergo productive biotransformation. To elucidate the molecular origin of this selectivity and define the catalytic mechanism, we combined molecular docking, substrate tunnel engineering, classical molecular dynamics, well-tempered metadynamics simulations, and experimental validation. Computational analyses show that both l-lysine and l-lysine ethyl ester can access and bind within the LCD active site, and tunnel engineering produced LCD variants (I61V-I94V-D236C and I61V-I94V-E264T) with improved tunnel properties. However, experimental assays demonstrated that these variants did not acquire catalytic activity toward l-lysine ethyl ester. Mechanistic simulations reveal that the proposed l-lysine iminium intermediate consistently adopts low-energy, cyclization-competent conformations in which the nucleophilic Nε and reactive Cα atoms achieve near-attack geometries. In contrast, the proposed l-lysine ethyl ester iminium intermediate populates higher-energy states with misaligned geometries and kinetically trapped conformations, suggesting difficult cyclization despite successful binding. These findings suggest that steric and dynamic constraintsrather than substrate accesscould impact the catalysis of esterified substrates. This work establishes a mechanistic framework linking enzyme dynamics, substrate recognition, and catalytic efficiency, providing a foundation for rational LCD engineering aimed at expanding substrate scope and guiding future industrial applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.